Document_and_Entity_Informatio
| Document and Entity Information | 3 Months Ended | |
| Mar. 31, 2014 | 14-May-14 | |
| Document And Entity Information | ' | ' |
| Entity Registrant Name | 'SPHERIX INC | ' |
| Entity Central Index Key | '0000012239 | ' |
| Document Type | '10-Q | ' |
| Document Period End Date | 31-Mar-14 | ' |
| Amendment Flag | 'false | ' |
| Current Fiscal Year End Date | '--12-31 | ' |
| Entity Well-known Seasoned Issuer | 'No | ' |
| Entity Voluntary Filers | 'No | ' |
| Entity Current Reporting Status | 'Yes | ' |
| Entity Filer Category | 'Smaller Reporting Company | ' |
| Entity Common Stock, Shares Outstanding | ' | 12,269,812 |
| Document Fiscal Year Focus | '2014 | ' |
| Document Fiscal Period Focus | 'Q1 | ' |
Condensed_Consolidated_Balance
| Condensed Consolidated Balance Sheets (USD $) | Mar. 31, 2014 | Dec. 31, 2013 |
| In Thousands, unless otherwise specified | ||
| Current assets | ' | ' |
| Cash and cash equivalents | $4,503 | $3,125 |
| Prepaid expenses and other assets | 107 | 151 |
| Total current assets | 4,610 | 3,276 |
| Patent portfolios, net of accumulated amortization of $2,695 and $267 | 62,407 | 64,835 |
| Goodwill | 1,712 | 1,712 |
| Deposit | 30 | 30 |
| Total assets | 68,759 | 69,853 |
| Current liabilities | ' | ' |
| Accounts payable and accrued expenses | 1,039 | 270 |
| Accrued salaries and benefits | 77 | 233 |
| Accrued patent cost | ' | 1,000 |
| Warrant liability | 8 | 48 |
| Total liabilities | 1,124 | 1,551 |
| Series I redeemable preferred stock, $0.0001 par value; 119,760 shares issued and outstanding; liquidation preference of $167 per share | 20,000 | 20,000 |
| Commitments and contingencies | ' | ' |
| Stockholders' equity | ' | ' |
| Common stock, $0.0001 par value, 200,000,000 shares and 50,000,000 shares authorized at March 31, 2014 and December 31, 2013, respectively; 8,206,335 shares and 3,770,113 shares issued at at March 31, 2014 and December 31, 2013, respectively; 8,196,107 and 3,769,712 shares outstanding at March 31, 2014 and December 31, 2013, respectively | 1 | ' |
| Additional paid-in-capital | 109,137 | 102,043 |
| Treasury stock, at cost, 228 shares at March 31, 2014 and 401 shares at December 31, 2013, respectively | -264 | -465 |
| Accumulated deficit | -61,239 | -53,276 |
| Total stockholders' equity | 47,635 | 48,302 |
| Total liabilities and stockholders' equity | 68,759 | 69,853 |
| Series A Preferred Stock [Member] | ' | ' |
| Stockholders' equity | ' | ' |
| Preferred stock | ' | ' |
| Series B Preferred Stock [Member] | ' | ' |
| Stockholders' equity | ' | ' |
| Preferred stock | ' | ' |
| Series C Convertible Preferred Stock [Member] | ' | ' |
| Stockholders' equity | ' | ' |
| Preferred stock | ' | ' |
| Series D Preferred Stock [Member] | ' | ' |
| Stockholders' equity | ' | ' |
| Preferred stock | ' | ' |
| Series D-1 Preferred [Member] | ' | ' |
| Stockholders' equity | ' | ' |
| Preferred stock | ' | ' |
| Series E Convertible Preferred Stock [Member] | ' | ' |
| Stockholders' equity | ' | ' |
| Preferred stock | ' | ' |
| Series F Convertible Preferred Stock [Member] | ' | ' |
| Stockholders' equity | ' | ' |
| Preferred stock | ' | ' |
| Series F-1 Convertible Preferred Stock [Member] | ' | ' |
| Stockholders' equity | ' | ' |
| Preferred stock | ' | ' |
| Series H Convertible Preferred Stock [Member] | ' | ' |
| Stockholders' equity | ' | ' |
| Preferred stock | ' | ' |
Condensed_Consolidated_Balance1
| Condensed Consolidated Balance Sheets (Parenthetical) (USD $) | Mar. 31, 2014 | Dec. 31, 2013 |
| In Thousands, except Share data, unless otherwise specified | ||
| Current assets | ' | ' |
| Patents, accumulated amortization (in dollars) | $2,695 | $267 |
| Stockholders' equity | ' | ' |
| Series I redeemable preferred stock, par value (in dollars per share) | $0.00 | $0.00 |
| Series I redeemable preferred stock, shares issued | 119,760 | 119,760 |
| Series I redeemable preferred stock, shares outstanding | 119,760 | 119,760 |
| Series I redeemable preferred stock, liquidation preference | $167 | $167 |
| Preferred stock, par value (in dollars per share) | $0.00 | $0.00 |
| Preferred stock, shares authorized | 5,000,000 | 5,000,000 |
| Common stock, par value (in dollars per share) | $0.00 | $0.00 |
| Common stock, shares authorized | 200,000,000 | 50,000,000 |
| Common stock, shares issued | 8,206,335 | 3,770,113 |
| Common stock, shares outstanding | 8,206,335 | 3,769,712 |
| Treasury stock, shares | 228 | 401 |
| Series A Preferred Stock [Member] | ' | ' |
| Stockholders' equity | ' | ' |
| Preferred stock, par value (in dollars per share) | $0.00 | ' |
| Preferred stock, shares authorized | 500,000 | ' |
| Preferred stock, shares issued | 0 | 0 |
| Preferred stock, shares outstanding | 0 | 0 |
| liquidation preference | $0.00 | $0.00 |
| Series B Preferred Stock [Member] | ' | ' |
| Stockholders' equity | ' | ' |
| Preferred stock, par value (in dollars per share) | $0.00 | ' |
| Preferred stock, shares issued | 1 | 1 |
| Preferred stock, shares outstanding | 1 | 1 |
| liquidation preference | $0.00 | $0.00 |
| Series C Convertible Preferred Stock [Member] | ' | ' |
| Stockholders' equity | ' | ' |
| Preferred stock, par value (in dollars per share) | $0.00 | ' |
| Preferred stock, shares issued | 1 | 1 |
| Preferred stock, shares outstanding | 1 | 1 |
| liquidation preference | $0.00 | $0.00 |
| Series D Preferred Stock [Member] | ' | ' |
| Stockholders' equity | ' | ' |
| Preferred stock, par value (in dollars per share) | $0.00 | ' |
| Preferred stock, shares issued | 18,000 | 1,227,582 |
| Preferred stock, shares outstanding | 18,000 | 1,227,582 |
| liquidation preference | $0.00 | $0.00 |
| Series D-1 Preferred [Member] | ' | ' |
| Stockholders' equity | ' | ' |
| Preferred stock, par value (in dollars per share) | $0.00 | ' |
| Preferred stock, shares issued | 945,139 | 59,265 |
| Preferred stock, shares outstanding | 945,139 | 59,265 |
| liquidation preference | $0.00 | $0.00 |
| Series E Convertible Preferred Stock [Member] | ' | ' |
| Stockholders' equity | ' | ' |
| Preferred stock, par value (in dollars per share) | $0.00 | ' |
| Preferred stock, shares issued | 0 | 0 |
| Preferred stock, shares outstanding | 0 | 0 |
| liquidation preference | $0.00 | $0.00 |
| Series F Convertible Preferred Stock [Member] | ' | ' |
| Stockholders' equity | ' | ' |
| Preferred stock, par value (in dollars per share) | $0.00 | ' |
| Preferred stock, shares issued | 0 | 0 |
| Preferred stock, shares outstanding | 0 | 0 |
| liquidation preference | $0.00 | $0.00 |
| Series F-1 Convertible Preferred Stock [Member] | ' | ' |
| Stockholders' equity | ' | ' |
| Preferred stock, par value (in dollars per share) | $0.00 | ' |
| Preferred stock, shares issued | 156,250 | 156,250 |
| Preferred stock, shares outstanding | 156,250 | 156,250 |
| liquidation preference | $0.00 | $0.00 |
| Series H Convertible Preferred Stock [Member] | ' | ' |
| Stockholders' equity | ' | ' |
| Preferred stock, par value (in dollars per share) | $0.00 | ' |
| Preferred stock, shares issued | 459,043 | 459,043 |
| Preferred stock, shares outstanding | 459,043 | 459,043 |
| liquidation preference | $0.00 | $0.00 |
Condensed_Consolidated_Stateme
| Condensed Consolidated Statements of Operations (USD $) | 3 Months Ended | |
| In Thousands, except Share data, unless otherwise specified | Mar. 31, 2014 | Mar. 31, 2013 |
| Condensed Consolidated Statements Of Operations | ' | ' |
| Revenue | $4 | $6 |
| Operating costs and expenses | ' | ' |
| Amortization of patents | 2,428 | ' |
| Compensation and related expenses (including stock-based compensation) | 3,532 | 455 |
| Depreciation | ' | 16 |
| Other selling, general and administrative | 2,053 | 446 |
| Total operating expenses | 8,013 | 917 |
| Loss from operations | -8,009 | -911 |
| Other income (expense) | ' | ' |
| Interest income | 6 | ' |
| Fair value adjustments for warrant liabilities | 40 | -2,786 |
| Total other income (expense) | 46 | -2,786 |
| Net loss | ($7,963) | ($3,697) |
| Net loss per share, basic and diluted | ($1.66) | ($5.35) |
| Weighted average number of shares outstanding Basic and diluted | 4,789,596 | 691,213 |
Condensed_Consolidated_Stateme1
| Condensed Consolidated Statements of Cash Flows (USD $) | 3 Months Ended | |
| In Thousands, unless otherwise specified | Mar. 31, 2014 | Mar. 31, 2013 |
| Cash flows from operating activities | ' | ' |
| Net loss | ($7,963) | ($3,697) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ' | ' |
| Amortization of patent portfolio | 2,428 | ' |
| Fair value adjustments for warrant liabilities | -40 | 2,786 |
| Depreciation | ' | 16 |
| Non-cash registration rights penalty | 700 | ' |
| Stock-based compensation | 3,396 | 4 |
| Changes in assets and liabilities: | ' | ' |
| Other receivables | ' | -1 |
| Prepaid expenses and other assets | 44 | 14 |
| Accounts payable and accrued expenses | 69 | -262 |
| Accrued salaries and benefits | -156 | ' |
| Net cash used in activities of continuing operations | -1,522 | -1,140 |
| Net cash provided by (used in) activities of discontinued operations | ' | 89 |
| Net cash used in operating activities | -1,522 | -1,051 |
| Cash flow from investing activities | ' | ' |
| Payment of accrued patent costs | -1,000 | ' |
| Net cash used in investing activities | -1,000 | ' |
| Cash flow from financing activities | ' | ' |
| Proceeds from issuance of common stock and warrants, net | 3,900 | ' |
| Net cash provided by financing activities | 3,900 | ' |
| Net decrease in cash and cash equivalents | 1,378 | -1,051 |
| Cash and cash equivalents, beginning of year | 3,125 | 4,498 |
| Cash and cash equivalents, end of year | 4,503 | 3,447 |
| Cash paid for interest and taxes | ' | ' |
| Non-cash investing and financing activities | ' | ' |
| Retirement of treasury stock | 201 | ' |
| Conversion of Series D-1 preferred stock to common stock | 1 | ' |
| Issuance of Series C Convertible Preferred Stock in connection with exchange of warrants | ' | $5,696 |
Organization_and_Description_o
| Organization and Description of Business | 3 Months Ended |
| Mar. 31, 2014 | |
| Notes to Financial Statements | ' |
| 1. Organization and Description of Business | ' |
| Organization and Description of Business | |
| Spherix Incorporated (“we” or the “Company”) is an intellectual property company incorporated in the State of Delaware that owns patented and unpatented intellectual property. The Company was formed in 1967 as a scientific research company and for much of its history pursued drug development including through Phase III clinical studies which were largely discontinued in 2012. Through the Company’s acquisition of patents and patent applications developed by Nortel Networks Corporation from Rockstar Consortium US, LP (“Rockstar”) and Harris Corporation from North South Holdings Inc. (“North South”) in 2013, the Company has expanded its activities and is a significant owner of intellectual property assets. | |
| The Company's strategy is to derive value from licensing, commercialization, settlement and litigation of patents. | |
| Amended and Restated Certificate of Incorporation and Elimination | |
| On April 24, 2014, the Company filed an Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware, which was previously approved by the stockholders at a meeting held on February 6, 2014. The Amended and Restated Certificate of Incorporation, among other things, increased the authorized number of shares of common stock and preferred stock to 200,000,000 shares from 50,000,000 shares and to 50,000,000 shares from 5,000,000 shares, respectively. The Amended and Restated Certificate of Incorporation also requires the Company to indemnify its directors, officer and agents and advance expenses to such persons to the fullest extent permitted by Delaware law. | |
| On April 23, 2014, the Company filed a Certificate of Elimination with the Secretary of State of the State of Delaware eliminating the Series B Convertible Preferred Stock, Series E Convertible Preferred Stock and Series F Convertible Preferred Stock and returning them to authorized but undesignated shares of preferred stock. No shares of the foregoing series of preferred stock were outstanding. |
Liquidity_and_Financial_Condit
| Liquidity and Financial Condition | 3 Months Ended | ||
| Mar. 31, 2014 | |||
| Notes to Financial Statements | ' | ||
| 2. Liquidity and Financial Condition | ' | ||
| The Company continues to incur ongoing administrative and other expenses, including public company expenses, in excess of corresponding revenue. The Company intends to finance its activities through: | |||
| · | managing current cash and cash equivalents on hand from the Company’s past equity offerings, | ||
| · | seeking additional funds raised through the sale of additional securities in the future, and | ||
| · | increasing revenue from its patent portfolios, license fees, and new business ventures. | ||
| As a result of the Company’s recurring operating losses and net operating cash flow deficits, there is substantial doubt about the Company’s ability to continue as a going concern. The condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern and do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the outcome of this uncertainty. | |||
| The Company is dependent on its ability to retain short term financing and ultimately to generate sufficient cash flow to meet its obligations on a timely basis in order to attain profitability, as well as successfully obtain financing on favorable terms to fund the Company’s long term plans. The Company’s business will require significant amounts of capital to sustain operations and make the investments it needs to execute its longer term business plan. The Company’s working capital amounted to approximately $3.5 million at March 31, 2014, and cash and cash equivalents amounted to approximately $4.5 million at March 31, 2014. The Company’s existing liquidity is not sufficient to fund its operations, anticipated capital expenditures, working capital and other financing requirements for the foreseeable future. The Company will need to seek to obtain additional debt or equity financing, especially if the Company experiences downturns or cyclical fluctuations in its business that are more severe or longer than anticipated, or if the Company experiences significant increases in expense levels resulting from being a publicly-traded company or operations. If the Company attempts to obtain additional debt or equity financing, the Company cannot assume that such financing will be available to the Company on favorable terms, or at all. | |||
| Disputes regarding the assertion of patents and other intellectual property rights are highly complex and technical. The Company may be forced to litigate against others to enforce or defend its intellectual property rights or to determine the validity and scope of other parties’ proprietary rights. The defendants or other third parties involved in the lawsuits in which the Company is involved may allege defenses and/or file counterclaims or initiate inter parties reviews in an effort to avoid or limit liability and damages for patent infringement or cause the Company to incur additional costs as a strategy. If such efforts are successful, they may have an impact on the value of the patents and preclude the Company from deriving revenue from the patents. The patents could be declared invalid by a court or the US Patent and Trademark Office, in whole or in part, or the costs of the Company can increase. Recent rulings also create an increased risk that if the Company is unsuccessful in litigation it could be responsible to pay the attorney's fees and other costs of defendants by lowering the standard for legal fee shifting sought by defendants in patent cases. | |||
| As a result, a negative outcome of any such litigation, or one or more claims contained within any such litigation, could materially and adversely impact the Company’s business. Additionally, the Company anticipates that legal fees which are not included in contingency fee arrangements, experts and other expenses will be material and could have an adverse effect on its financial condition and results of operations if its efforts to monetize its patents are unsuccessful. | |||
| In addition, the costs of enforcing the Company’s patent rights may exceed its recoveries from such enforcement activities. Accordingly, in order for the Company to generate a profit from its patent enforcement and monetization activities, the revenues from such enforcement and monetization activities must be high enough to offset both the cash outlays and the contingent fees payable from such revenues, including any profit sharing arrangements with inventors or prior owners of the patents. The Company’s failure to monetize its patent assets or the occurrence of unforeseen circumstances that could have a negative impact on the Company’s liquidity could significantly harm its business. | |||
Summary_of_Significant_Account
| Summary of Significant Accounting Policies | 3 Months Ended | ||||||||
| Mar. 31, 2014 | |||||||||
| Notes to Financial Statements | ' | ||||||||
| 3. Summary of Significant Accounting Policies | ' | ||||||||
| Basis of Presentation and Principles of Consolidation | |||||||||
| The accompanying condensed consolidated financial statements of the Company are unaudited and do not include all of the information and disclosures generally required for annual financial statements. In the opinion of management, the statements contain all material adjustments (consisting of normal recurring accruals) necessary to present fairly the Company’s consolidated financial position as of March 31, 2014, the condensed consolidated results of its operations and cash flows for the three month periods ended March 31, 2014 and 2013. This report should be read in conjunction with the Company’s Annual Report on Form 10-K, which does contain the complete information and disclosure, for the year ended December 31, 2013. | |||||||||
| The accompanying condensed consolidated financial statements include the accounts of Spherix Incorporated and its wholly-owned subsidiaries, Biospherics Incorporated, Nuta Technology Corp., Spherix Portfolio Acquisition I, Inc. ("SPXI"), Spherix Portfolio Acquisition II, Inc. ("SPXII"), Guidance IP, LLC (“Guidance”), CompuFill LLC ("CompuFill") and Directional IP, LLC. (“Directional”). All significant intercompany balances and transactions have been eliminated in consolidation. | |||||||||
| Use of Estimates | |||||||||
| The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“US GAAP”). This requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the period. The Company’s significant estimates and assumptions include the recoverability and useful lives of long-lived assets, stock-based compensation, valuation of warrants, the valuation of assets acquired and common and preferred stock issued in the acquisition of North South, and the valuation allowance related to the Company’s deferred tax assets. Certain of the Company’s estimates, including the carrying amount of the intangible assets, could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates and assumptions. | |||||||||
| Intangible Assets – Patent Portfolios | |||||||||
| "Intangible assets" include the Company’s patent portfolios with original estimated useful lives ranging from 6 months to 12 years. The Company amortizes the cost of the intangible assets over their estimated useful lives on a straight line basis. Costs incurred to acquire patents, including legal costs, are also capitalized as long-lived assets and amortized on a straight-line basis with the associated patent. As disclosed in Note 1, the Company acquired its current patent portfolios during 2013. | |||||||||
| "Patents" includes the cost of patents or patent rights (hereinafter, collectively “patents”), acquired from third-parties or acquired in connection with business combinations. Patent acquisition costs are amortized utilizing the straight-line method over their remaining economic useful lives, ranging from one to ten years. Certain patent application and prosecution costs incurred to secure additional patent claims, that based on management’s estimates are deemed to be recoverable, are capitalized and amortized over the remaining estimated economic useful life of the related patent portfolio. | |||||||||
| Goodwill | |||||||||
| Goodwill is the excess of cost of an acquired entity over the fair value of amounts assigned to assets acquired and liabilities assumed in a business combination. Goodwill is subject to impairment testing at least annually and will be tested for impairment between annual tests if an event occurs or circumstances change that indicate the carrying amount may be impaired. ASC Topic 350 provides an entity with the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If, after assessing the totality of events or circumstances, an entity determines it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then performing the two-step impairment test is unnecessary. If the two-step impairment test is necessary, a fair-value-based test is applied at the reporting unit level, which is generally one level below the operating segment level. The test compares the fair value of an entity's reporting units to the carrying value of those reporting units. This test requires various judgments and estimates. The Company estimates the fair value of the reporting unit using a market approach in combination with a discounted operating cash flow approach. Impairment of goodwill is measured as the excess of the carrying amount of goodwill over the fair values of recognized and unrecognized assets and liabilities of the reporting unit. An adjustment to goodwill will be recorded for any goodwill that is determined to be impaired. The Company tests goodwill for impairment at least annually in conjunction with the preparation of its annual business plan, or more frequently if events or circumstances indicate it might be impaired. ASU 2010-28 modifies Step 1 of the goodwill impairment test for reporting units with zero or negative carrying amounts. For those reporting units, an entity is required to perform Step 2 of the goodwill impairment test if it is more likely than not that a goodwill impairment exists. In determining whether it is more likely than not that goodwill impairment exists, an entity should consider whether there are any adverse qualitative factors indicating that impairment may exist. | |||||||||
| Impairment of Long-lived Assets | |||||||||
| The Company monitors the carrying value of long-lived assets for potential impairment and tests the recoverability of such assets whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable. If a change in circumstance occurs, the Company performs a test of recoverability by comparing the carrying value of the asset or asset group to its undiscounted expected future cash flows. If cash flows cannot be separately and independently identified for a single asset, the Company will determine whether impairment has occurred for the group of assets for which the Company can identify the projected cash flows. If the carrying values are in excess of undiscounted expected future cash flows, the Company measures any impairment by comparing the fair value of the asset or asset group to its carrying value. The Company deemed there was no impairment of long-lived assets during the three months ended March 31, 2014. | |||||||||
| Net Loss Per Share | |||||||||
| Basic loss per share is computed by dividing the net income or loss applicable to common shares by the weighted average number of common shares outstanding during the period. Diluted earnings per share is computed using the weighted average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options (using the treasury stock method) and the conversion of the Company’s convertible preferred stock and warrants (using the if-converted method). Diluted loss per share excludes the shares issuable upon the conversion of preferred stock and the exercise of stock options and warrants from the calculation of net loss per share if their effect would be anti-dilutive. | |||||||||
| Securities that could potentially dilute loss per share in the future that were not included in the computation of diluted loss per share at March 31, 2014 and 2013 are as follows: | |||||||||
| For the three months | |||||||||
| ended March 31, | |||||||||
| 2014 | 2013 | ||||||||
| Convertible preferred stock | 16,773,275 | 229,341 | |||||||
| Warrants to purchase common stock | 775,021 | 75,757 | |||||||
| Non-vested restricted stock awards | 10,000 | 122,500 | |||||||
| Options to purchase common stock | 3,323,876 | 7,163 | |||||||
| Total | 20,802,172 | 434,761 | |||||||
| Stock-based Compensation | |||||||||
| The Company accounts for share-based payment awards exchanged for employee services at the estimated grant date fair value of the award. Stock options issued under the Company’s long-term incentive plans are granted with an exercise price equal to no less than the market price of the Company’s stock at the date of grant and expire up to ten years from the date of grant. These options generally vest over a four- to ten-year period. | |||||||||
| The fair value of stock options granted was determined on the grant date using assumptions for risk free interest rate, the expected term, expected volatility, and expected dividend yield. The risk free interest rate is based on U.S. Treasury zero-coupon yield curve over the expected term of the option. The expected term assumption is determined using the weighted average midpoint between vest and expiration for all individuals within the grant. The expected volatility assumption is based on the standard deviation of the Company’s underlying stock price’s daily logarithmic returns. | |||||||||
| The Company’s model includes a zero dividend yield assumption, as the Company has not historically paid nor does it anticipate paying dividends on its common stock. The Company’s model does not include a discount for post-vesting restrictions, as the Company has not issued awards with such restrictions. | |||||||||
| The periodic expense is then determined based on the valuation of the options, and at that time an estimated forfeiture rate is used to reduce the expense recorded. The Company estimates of pre-vesting forfeitures is primarily based on the Company’s historical experience and is adjusted to reflect actual forfeitures as the options vest. | |||||||||
| Treasury Stock | |||||||||
| The Company accounts for the treasury stock using the cost method, which treats it as a reduction in stockholders’ equity. | |||||||||
| Preferred Stock | |||||||||
| The Company applies the accounting standards for distinguishing liabilities from equity when determining the classification and measurement of its preferred stock. Preferred shares subject to mandatory redemption are classified as liability instruments and are measured at fair value. Conditionally redeemable preferred shares (including preferred shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, preferred shares are classified as stockholders’ equity. | |||||||||
Goodwill_and_Intangible_Assets
| Goodwill and Intangible Assets | 3 Months Ended | ||||||||||||||||
| Mar. 31, 2014 | |||||||||||||||||
| Notes to Financial Statements | ' | ||||||||||||||||
| 4. Goodwill and Intangible Assets | ' | ||||||||||||||||
| Acquisition of North South | |||||||||||||||||
| As disclosed in Note 1, on September 10, 2013, the Company completed its acquisition of North South. The Company acquired North South to expand its patent portfolio and continue its business plan of the monetization of its intellectual property. The Company accounted for its acquisition of North South using the acquisition method of accounting. | |||||||||||||||||
| The following table presents the unaudited pro-forma financial results, as if the acquisition of North South had been completed as of January 1, 2013 (in thousands, except per share amounts): | |||||||||||||||||
| For the three months ended | |||||||||||||||||
| 31-Mar-13 | |||||||||||||||||
| Revenues | $ | 53 | |||||||||||||||
| Net loss | $ | (3,810 | ) | ||||||||||||||
| Loss per share - basic and diluted | $ | (5.51 | ) | ||||||||||||||
| The unaudited pro-forma results of operations are presented for information purposes only. The unaudited pro-forma results of operations are not intended to present actual results that would have been attained had the acquisition been completed as of January 1, 2013 or to project potential operating results as of any future date or for any future periods. | |||||||||||||||||
| Other Intangible Assets | |||||||||||||||||
| The Company’s only identifiable intangible assets are patents and patent rights, with estimated remaining economic useful lives ranging from 6 months to 12 years. For all periods presented, all of the Company’s identifiable intangible assets were subject to amortization. The gross carrying amounts and accumulated amortization related to acquired intangible assets as of March 31, 2014 are as follows (in thousands, except year amounts): | |||||||||||||||||
| Date Acquired and Description | Intangible Assets at December 31, 2013, net | Weighted Average Life (in years) | Amortization Expense for the Three Months Ended March 31, 2014 | Amount Recorded as of March 31, 2014, net | |||||||||||||
| 7/24/13 - Rockstar patent portfolio | $ | 3,792 | 8.5 | $ | 115 | $ | 3,677 | ||||||||||
| 9/10/13 - North South patent portfolio | 1,062 | 8.5 | 32 | 1,030 | |||||||||||||
| 12/31/13 - Rockstar patent portfolio | 59,981 | 6.5 | 2,281 | 57,700 | |||||||||||||
| $ | 64,835 | $ | 2,428 | $ | 62,407 | ||||||||||||
| The weighted average remaining amortization period of the Company’s patents is approximately 6.4 years. Amortization for the year ended 2013, three months ended March 31, 2014 and future amortization of all patents is as follows (in thousands): | |||||||||||||||||
| Rockstar | North South | Rockstar | |||||||||||||||
| Portfolio | Portfolio | Portfolio | |||||||||||||||
| Acquired | Acquired | Acquired | Total | ||||||||||||||
| July 24, | September 10, | December 13, | Amortization | ||||||||||||||
| 2013 | 2013 | 2013 | |||||||||||||||
| Nine Months Ended December 31, 2014 | 355 | 98 | 6,950 | 7,403 | |||||||||||||
| 31-Dec-15 | 470 | 130 | 9,225 | 9,825 | |||||||||||||
| 31-Dec-16 | 471 | 130 | 9,250 | 9,851 | |||||||||||||
| 31-Dec-17 | 470 | 130 | 9,225 | 9,825 | |||||||||||||
| 31-Dec-18 | 470 | 130 | 9,225 | 9,825 | |||||||||||||
| Thereafter | 1,441 | 412 | 13,825 | 15,678 | |||||||||||||
| Total | $ | 3,677 | $ | 1,030 | $ | 57,700 | $ | 62,407 | |||||||||
Stockholders_Equity
| Stockholders' Equity | 3 Months Ended | ||||||||||||||||
| Mar. 31, 2014 | |||||||||||||||||
| Notes to Financial Statements | ' | ||||||||||||||||
| 5. Stockholders' Equity | ' | ||||||||||||||||
| Preferred Stock | |||||||||||||||||
| The Company had certificates of designation of ten separate series as summarized below as of March 31, 2014 and December 31, 2013: | |||||||||||||||||
| Number of Shares Issued | |||||||||||||||||
| and Outstanding as of | |||||||||||||||||
| March 31, | December 31, | Par Value | Conversion Ratio | ||||||||||||||
| 2014 | 2013 | ||||||||||||||||
| Series "A" | - | - | $ | 0.0001 | N/A | ||||||||||||
| Series "B" | 1 | 1 | 0.0001 | 4:01 | |||||||||||||
| Series "C" | 1 | 1 | 0.0001 | 1:01 | |||||||||||||
| Series “D" | 18,000 | 1,227,582 | 0.0001 | 10:01 | |||||||||||||
| Series “D-1" | 945,139 | 59,265 | 0.0001 | 10:01 | |||||||||||||
| Series “E” | - | - | 0.0001 | 1:01 | |||||||||||||
| Series “F" | - | - | 0.0001 | 1:01 | |||||||||||||
| Series “F-1" | 156,250 | 156,250 | 0.0001 | 1:01 | |||||||||||||
| Series “H" | 459,043 | 459,043 | 0.0001 | 10:01 | |||||||||||||
| Series “I” | 119,760 | 119,760 | 0.0001 | 20:01 | |||||||||||||
| Series A Preferred Stock | |||||||||||||||||
| The Company’s board of directors has designated 500,000 shares of its preferred stock as Series A Participating Preferred Stock (“Series A Preferred Stock”). | |||||||||||||||||
| On January 1, 2013, the Company adopted a stockholder rights plan in which rights to purchase shares of Series A Preferred Stock were distributed as a dividend at the rate of one right for each share of common stock. The rights are designed to guard against partial tender offers and other abusive and coercive tactics that might be used in an attempt to gain control of Spherix or to deprive its stockholders of their interest in the long-term value of Spherix. These rights seek to achieve these goals by forcing a potential acquirer to negotiate with the board of directors (or go to court to try to force the Board of Directors to redeem the rights), because only the Board of Directors can redeem the rights and allow the potential acquirer to acquire the Company’s shares without suffering very significant dilution. However, these rights also could deter or prevent transactions that stockholders deem to be in their interests, and could reduce the price that investors or an acquirer might be willing to pay in the future for shares of the Company’s common stock. | |||||||||||||||||
| Each right entitles the registered holder to purchase one one-hundredth of a share (a “Unit”) of the Company’s Series A Preferred Stock. Each Unit of Series A Preferred Stock will be entitled to an aggregate dividend of 100 times the dividend declared per share of common stock. In the event of liquidation, the holders of the Units of Series A Preferred Stock will be entitled to an aggregate payment of 100 times the payment made per share of common stock. Each Unit of Series A Preferred Stock will have 100 votes, voting together with the common stock. Finally, in the event of any merger, consolidation or other transaction in which shares of common stock are exchanged, each Unit of Series A Preferred Stock will be entitled to receive 100 times the amount received per share of common stock. These rights are protected by customary anti-dilution provisions. | |||||||||||||||||
| The rights will be exercisable only if a person or group acquires ten percent (10%) or more of the Company’s common stock (subject to certain exceptions stated in the plan) or announces a tender offer the consummation of which would result in ownership by a person or group of ten percent (10%) or more of the Company’s common stock. The board of directors may redeem the rights at a price of $0.001 per right. The rights will expire at the close of business on December 31, 2017 unless the expiration date is extended or unless the rights are earlier redeemed or exchanged by the Company. | |||||||||||||||||
| Series B Convertible Preferred Stock | |||||||||||||||||
| In connection with an offering of securities, which the Company closed in October 2010, the Company created a Series B Convertible Preferred Stock. All shares of Series B Convertible Preferred Stock issued in the offering have been converted to common stock except for one (1) outstanding share of Series B Convertible Preferred Stock as of March 31, 2014 and December 31, 2013. | |||||||||||||||||
| The Series B Convertible Preferred Stock is convertible at the option of the holder at any time into shares of the Company’s common stock at a conversion ratio determined by dividing the stated value of the convertible preferred stock, or $1,000, by a conversion price of $250 per share. The conversion price is subject to adjustment in the case of stock splits, stock dividends, combination of shares and similar recapitalization transactions. The conversion price may also be subject to adjustment if the Company issues rights, options or warrants to all holders of its common stock entitling them to subscribe for or purchase shares of its common stock at a price per share less than the daily volume weighted average price of its common stock, if the Company distributes evidence of its indebtedness or assets or rights or warrants to subscribe for or purchase any security to all holders of its common stock, or if the Company consummates a fundamental corporate transaction such as a merger or consolidation, sale or other disposition of all or substantially all of its assets, or an exchange or tender offer accepted by the holders of 50% or more of the Company’s outstanding common stock. Subject to limited exceptions, a holder of shares of Series B Convertible Preferred Stock will not have the right to convert any portion of its Series B Convertible Preferred Stock if the holder, together with its affiliates, would beneficially own in excess of 4.99% of the number of shares of the Company’s common stock outstanding immediately after giving effect to its conversion. The Series B Convertible Preferred Stock is entitled to receive dividends (on an “as converted to common stock” basis) to and in the same form as dividends actually paid on shares of the Company’s common stock. Except as required by law, holders of the Series B Convertible Preferred Stock are generally not entitled to voting rights. | |||||||||||||||||
| Series C Convertible Preferred Stock | |||||||||||||||||
| On March 6, 2013, the Company and certain investors that participated in the November 2012 private placement transaction, entered into separate Warrant Exchange Agreements pursuant to which the investors exchanged common stock purchase warrants acquired in the private placement transaction for 229,337 shares of the Company’s Series C Convertible Preferred Stock. Each share of Series C Convertible Preferred Stock is convertible into one (1) share of common stock at the option of the holder. The Series C Convertible Preferred Stock was established on March 5, 2013 by the filing in the State of Delaware of a Certificate of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock. During the year ended December 31, 2013, 229,336 shares of Series C Convertible Preferred Stock were converted into 229,336 shares of common stock. As of March 31, 2014 and December 31, 2013, one (1) share of Series C Convertible Preferred Stock was outstanding. | |||||||||||||||||
| Series D Convertible Preferred Stock | |||||||||||||||||
| In connection with the acquisition of North South in September of 2013, the Company issued 1,379,685 shares of its Series D Convertible Preferred Stock to the stockholders of North South. Each share of Series D Preferred Stock has a stated value of $0.0001 per share and is convertible into ten (10) shares of common stock. Upon the liquidation, dissolution or winding up of the Company’s business, each holder of Series D Preferred Stock shall be entitled to receive, for each share of Series D Preferred Stock held, a preferential amount in cash equal to the greater of (i) the Stated Value or (ii) the amount the holder would receive as a holder of the Company’s common stock on an “as converted” basis. Each holder of Series D Preferred Stock shall be entitled to vote on all matters submitted to its stockholders and shall be entitled to such number of votes equal to the number of shares of common stock such shares of Series D Preferred are convertible into at such time, taking into account the beneficial ownership limitations set forth in the governing Certificate of Designation and the Conversion Limit limitations described below. At no time may shares of Series D Preferred Stock be converted if such conversion would cause the holder to hold in excess of 4.99% of the Company’s issued and outstanding common stock, subject to an increase in such limitation up to 9.99% of the issued and outstanding common stock on 61 days’ written notice to the Company. The conversion ratio of the Series D Preferred Stock is subject to adjustment in the event of stock dividends, splits and fundamental transactions. | |||||||||||||||||
| During the three months ended March 31, 2014, 1,209,582 shares of Series D Convertible Preferred Stock were exchanged for Series D-1 Convertible Preferred Stock (see below). As of March 31, 2014, 18,000 shares of Series D Convertible Preferred Stock were issued and outstanding. | |||||||||||||||||
| Series D-1 Convertible Preferred Stock | |||||||||||||||||
| The Company’s Series D-1 Convertible Preferred Stock (“Series D-1 Preferred Stock”) was established on November 22, 2013. Each share of Series D-1 Preferred Stock has a stated value of $0.0001 per share and is convertible into ten (10) shares of common stock. Upon the liquidation, dissolution or winding up of the Company’s business, each holder of Series D-1 Preferred Stock shall be entitled to receive, for each share of Series D-1 Preferred Stock held, a preferential amount in cash equal to the greater of (i) the stated value or (ii) the amount the holder would receive as a holder of the Company’s common stock on an “as converted” basis. Each holder of Series D-1 Preferred Stock shall be entitled to vote on all matters submitted to the Company’s stockholders and shall be entitled to such number of votes equal to the number of shares of common stock such shares of Series D-1 Preferred are convertible into at such time, taking into account the beneficial ownership limitations set forth in the governing Certificate of Designation. At no time may shares of Series D-1 Preferred Stock be converted if such conversion would cause the holder to hold in excess of 9.99% of the Company’s issued and outstanding common stock. The conversion ratio of the Series D Preferred Stock is subject to adjustment in the event of stock dividends, splits and fundamental transactions. The Company commenced an exchange with holders of Series D Convertible Preferred Stock pursuant to which the holders of the Company’s outstanding shares of Series D Preferred Stock acquired in the Merger could exchange such shares for shares of the Company’s Series D-1 Preferred Stock on a one-for-one basis. | |||||||||||||||||
| On January 27, 2014, Spherix Incorporated (the “Company”) entered into a lockup agreement with certain holders of an aggregate of 1,508,148 shares of the Company’s common stock, $0.0001 par value per share (the “Common Stock”) and shares of Common Stock issuable upon conversion of shares of Series D-1 Convertible Preferred Stock, which are included in the Company’s Registration Statement on Form S-1 (File No.333-192737) (the “Lockup Agreement” and such 1,508,148 shares, the “Locked Up Shares”). The holders of the Locked Up Shares have agreed, for so long as such holders own such shares, not to sell any Locked Up Shares unless either (i) if such sale price is at least $6.00 per share, the cumulative amount sold by such holder (including the anticipated sale) does not exceed such holder's pro rata portion of 60% of the composite aggregate trading volume of the Common Stock during the period beginning on the date that the Registration Statement is declared effective and ending on the date of sale (the “Lockup Measuring Period) or (ii), if the sale price is less than $6.00 per share, the cumulative amount sold by such holder does not exceed such holder's pro rata portion of 20% of the composite aggregate trading volume during the Lockup Measuring Period. | |||||||||||||||||
| During the three months ended March 31, 2014, (a) 1,209,582 shares of Series D Convertible Preferred Stock were exchanged for Series D-1 Convertible Preferred Stock (see above) and (b) 323,708 shares of D-1 were converted into 3,237,080 shares of common stock. As of March 31, 2014, 945,139 shares of Series D-1 Convertible Preferred Stock were issued and outstanding. | |||||||||||||||||
| Series F-1 Convertible Preferred Stock | |||||||||||||||||
| The Company’s Series F-1 Convertible Preferred Stock (“Series F-1 Preferred Stock”) was established on November 22, 2013. Each share of Series F-1 Preferred Stock is convertible, at the option of the holder at any time, into one (1) share of common stock and has a stated value of $0.0001. Such conversion ratio is subject to adjustment in the case of stock splits, stock dividends, combination of shares and similar recapitalization transactions. Each share of Series F-1 Preferred Stock is entitled to 91% of one vote per share (subject to beneficial ownership limitation) and shall vote together with holders of the Company’s common Stock. The Company is prohibited from effecting the conversion of the Series F-1 Preferred Stock to the extent that, as a result of such conversion, the holder will beneficially own more than 9.99% in the aggregate of the issued and outstanding shares of the Company’s common stock calculated immediately after giving effect to the issuance of shares of common stock upon the conversion of the Series F-1 Preferred Stock. As of March 31, 2014 and December 31, 2013, 156,250 shares of Series F-1 Preferred Stock were outstanding. | |||||||||||||||||
| Series H Convertible Preferred Stock | |||||||||||||||||
| On December 31, 2013, the Company designated 459,043 shares of preferred stock as Series H Convertible Preferred Stock (“Series H Preferred Stock”). On December 31, 2013, the Company issued approximately $38.3 million of Series H Preferred Stock (or 459,043 shares) to Rockstar. Each share of Series H Preferred Stock is convertible into ten (10) shares of common stock and has a stated value of $83.50. The conversion ratio is subject to adjustment in the event of stock splits, stock dividends, combination of shares and similar recapitalization transactions. The Company is prohibited from effecting the conversion of the Series H Preferred Stock to the extent that, as a result of such conversion, the holder beneficially owns more than 4.99% (which may be increased to 9.99% and subsequently to 19.99%, each upon 61 days’ written notice), in the aggregate, of the Company’s issued and outstanding shares of common stock calculated immediately after giving effect to the issuance of shares of common stock upon the conversion of the Series H Preferred Stock. Holders of the Series H Preferred Stock shall be entitled to vote on all matters submitted to the Company’s stockholders and shall be entitled to the number of votes equal to the number of shares of common stock into which the shares of Series H Preferred Stock are convertible, subject to applicable beneficial ownership limitations. The Series H Preferred Stock provides a liquidation preference of $83.50 per share. The shares of Series H Preferred Stock were not immediately convertible and did not possess any voting rights until such a time as the Company had obtained stockholder approval of the issuance, pursuant to NASDAQ Listing Rule 5635. On April 16, 2014, the Company obtained the required shareholder approval pursuant to NASDAQ Listing Rule 5635 and, as a result, all outstanding shares of Series H Preferred Stock are convertible and possess voting rights in accordance with its terms. As of March 31, 2014 and December 31, 2013, 459,043 shares of Series H Preferred Stock were outstanding. | |||||||||||||||||
| Series I Preferred Convertible Stock | |||||||||||||||||
| On December 31, 2013, the Company designated 119,760 shares of preferred stock as Series I Convertible Preferred Stock (“Series I Preferred Stock”). On December 31, 2013, the Company issued approximately $20 million (or 119,760 shares) of Series I Preferred Stock to Rockstar. Each share of Series I Preferred Stock is convertible into twenty (20) shares of the Company’s common stock and has a stated value of $167. The conversion ratio is subject to adjustment in the event of stock splits, stock dividends, combination of shares and similar recapitalization transactions. The holder is prohibited from converting the Series I Preferred Stock to the extent that, as a result of such conversion, the holder beneficially owns more than 4.99% (which may be increased to 9.99% and subsequently to 19.99%, each upon 61 days’ written notice), in the aggregate, of the Company’s issued and outstanding shares of common stock calculated immediately after giving effect to the issuance of shares of common stock upon the conversion of the Series I Preferred Stock. Holders of the Series I Preferred Stock shall be entitled to vote on all matters submitted to its stockholders and shall be entitled to the number of votes equal to the number of shares of common stock into which the shares of Series I Preferred Stock are convertible, subject to applicable beneficial ownership limitations. The Series I Preferred stock provides for a liquidation preference of $167 per share. | |||||||||||||||||
| The Series I Preferred Stock contains a mandatory redemption date of December 31, 2015 as to 100% of the Series I Preferred Stock then outstanding, requiring a minimum of 25% of the total number of shares of Series I Preferred Stock issued to be redeemed (less the amount of any conversions occurring prior thereto) on or prior to each of June 30, 2014, December 31, 2014, June 30, 2015 and December 31, 2015 (each, a “Partial Redemption Date” and each payment, a “Redemption Payment”). On each Partial Redemption Date, the Company is required to pay Rockstar a Redemption Payment equal to the lesser of (i) such number of shares of Series I Preferred Stock as have a stated value of $5.0 million; or (ii) such number of shares of Series I Preferred Stock as shall, together with all voluntary and mandatory redemptions and conversions to common stock occurring prior to the applicable Partial Redemption Date, have a stated value of $5.0 million; or (iii) the remaining shares of Series I Preferred Stock issued and outstanding if such shares have a stated value of less than $5.0 million, in an amount of cash equal to its stated value plus all accrued but unpaid dividends, distributions and interest thereon, unless Rockstar, in its sole discretion, elects to waive such Redemption Payment or convert such shares (or a portion thereof) into common stock. No interest or dividends are payable on the Series I Preferred Stock unless the Company fails to make the first $5.0 million Partial Redemption Payment due June 30, 2014, then interest shall accrue on the outstanding stated value of all outstanding shares of Series I Preferred Stock at a rate of fifteen (15%) per annum from January 1, 2014. The Company’s obligations to pay the Redemption Payments and any interest payments in connection therewith are secured pursuant to the terms of a Security Agreement under which the Rockstar Patents serve as collateral security. No action can be taken under the Security Agreement unless the Company has failed to make a second redemption payment of $5.0 million due December 31, 2014. The Security Agreement contains additional usual and customary “Events of Default” (as such term is defined in the Intellectual Property Security Agreement) under which Rockstar can take action, including a sale to a third party or reduction of secured amounts via transfer of the Rockstar Patents to Rockstar. | |||||||||||||||||
| Additionally, in the event the Company consummates a Fundamental Transaction (as defined in the Certificate of Designation of Preferences, Rights and Limitations of Series I Convertible Preferred Stock), the Company shall be required to redeem such portion of the outstanding shares of Series I Preferred Stock as shall equal (i) 50% of the net proceeds of the Fundamental Transaction after deduction of the amount of net proceeds required to leave the Company with cash and cash equivalents on hand of $5.0 million and up until the net proceeds leave the Company with cash and cash equivalents on hand of $7.5 million and (ii) 100% of the net proceeds of the Fundamental Transaction thereafter. | |||||||||||||||||
| The shares of Series I Preferred Stock were not immediately convertible and did not possess any voting rights until such a time as the Company had obtained stockholder approval of the issuance, pursuant to NASDAQ Listing Rule 5635. On April 16, 2014, the Company obtained the required shareholder approval pursuant to NASDAQ Listing Rule 5635 and, as a result, all outstanding shares of Series I Convertible Preferred Stock are convertible and possess voting rights in accordance with its terms. | |||||||||||||||||
| As of March 31, 2014 and December 31, 2013, 119,760 shares of Series I Preferred Stock were outstanding. | |||||||||||||||||
| Common Stock | |||||||||||||||||
| Private Placement | |||||||||||||||||
| On March 26, 2014, the Company sold an aggregate of $4,446,081 of its securities in a private offering made solely to accredited investors (the “Investors”) (the “Offering”) pursuant to Subscription Agreements, dated as of March 26, 2014 (the “Subscription Agreement”). Pursuant to the Offering, Investors purchased (i) 1,185,614 shares (the “Shares”) of common stock, par value $0.0001 per share, of the Company (“Common Stock”) and (ii) five year warrants to purchase an aggregate of 592,794 shares of Common Stock of the Company, at an exercise price of $6.15 per share (the “Warrants”). The Warrants are exercisable on and following the six month anniversary of the date of issuance by payment to the Company of the exercise price of $6.15 per share, or if a registration statement covering the Common Stock underlying the Warrants is not then in effect, on a cashless basis. Each Warrant may be callable at $0.01 per Warrant upon the consummation of a Company financing with a per-share offering price of at least $8.00 and net proceeds to the Company from such offering of at least $15 million. The expected use of proceeds from the Offering is for general corporate purposes and working capital. | |||||||||||||||||
| The Company is required to register with the United States Securities and Exchange Commission (“SEC”) all Shares and the shares of Common Stock underlying the Warrants issued in the Offering (including the placement agent warrant described below) by filing within 30 days of closing a registration statement with the SEC and is required to cause such registration statement to be declared effective by the SEC within 180 days of the filing date (a registration statement was filed on April 17, 2014) unless the SEC notifies the Company that it will not be reviewing the registration statement, then in which case the Company must cause the registration statement to be declared effective within 30 days of such notification but in any event, within 60 days of the filing date. The Investors have also been granted certain “piggy back” registration rights. In the event the Company fails to file the registration statement or cause such registration statement to be declared effective by the SEC, the Company is required to pay to each Investor a cash payment equal to one (1.0%) percent of the aggregate purchase price paid by such Investor pursuant to the Subscription Agreement, on each 30 day anniversary of such event until the applicable event is cured (but not in excess of fifteen (15%) percent of such Investor’s purchase price). | |||||||||||||||||
| The Company incurred aggregate costs associated with the Offering of approximately $572,000, and issued a five-year warrant to purchase 118,561 shares of Common Stock to the placement agent (Laidlaw and Company Ltd.) at an exercise price of $4.67 per share of Common Stock (the “Placement Agent Warrant”). The Placement Agent Warrant is exercisable beginning on the six month anniversary of the date of issuance. | |||||||||||||||||
| Stock Grants | |||||||||||||||||
| On January 23, 2014, the Company issued 2,000 shares of fully vested common stock to two consultants in return for services rendered. On March 3, 2014 the Company issued 1,700 shares of fully vested common stock for consulting services. The fair value of these stock grants was $24,990 based upon the closing price on the date of the grant. | |||||||||||||||||
| Warrants | |||||||||||||||||
| A summary of warrant activity for the three months ended March 31, 2014 is presented below: | |||||||||||||||||
| Warrants | Weighted Average Exercise Price | Total Intrinsic Value | |||||||||||||||
| Outstanding as of December 31, 2013 | 65,263 | $ | 5.83 | - | |||||||||||||
| Issued | 711,355 | 5.9 | |||||||||||||||
| Cancelled | (1,597 | ) | 28 | ||||||||||||||
| Outstanding as of March 31, 2014 | 775,021 | $ | 5.85 | $ | - | ||||||||||||
| Stock Options | |||||||||||||||||
| 2014 Plan and Option Grants | |||||||||||||||||
| On January 28, 2014, the Company approved the adoption of a director compensation program (the “Program”) for non-employee directors pursuant to and subject to the available number of shares reserved under the Spherix Incorporated 2014 Equity Incentive Plan (the “2014 Plan”). Pursuant to the Program, and pursuant to and subject to the available number of shares reserved under Plan, each non-employee director shall annually be awarded 75,000 non-qualified stock options (the “Director Options”) to acquire shares of common stock, par value $0.0001 per share, of the Company (the “Common Stock”) commencing with the annual meeting of stockholders of the Company for the 2015 fiscal year of the Company. | |||||||||||||||||
| Each Director Option shall have a term of five (5) years and shall vest in two equal annual installments with 50% vesting immediately on the date of issue and the remaining 50% on the one year anniversary of the date of issue so long as the director has not been removed for cause. Each Director Option shall be granted on the date of the annual meeting of stockholders at which directors are elected and shall have an exercise price equal to the closing price of Common Stock on the trading day immediately preceding the date of issuance. | |||||||||||||||||
| On January 28, 2014, pursuant to and subject to the available number of shares reserved under the 2014 Plan, the Company issued 75,000 Director Options with an exercise price of $5.83 to each of the following non-employee directors: Robert Vander Zanden, Douglas Brown, Edward Karr, Harvey Kesner, Alexander Poltorak. | |||||||||||||||||
| Also on January 28, 2014, pursuant to and subject to the available number of shares reserved under the 2014 Plan, the Company issued non-qualified options with a term of five (5) years and an exercise price of $5.83 to the individuals below for the number of shares of Common Stock set forth opposite their respective names: | |||||||||||||||||
| · | Edward Karr – 200,000 shares, vesting in two equal annual installments with 50% vesting immediately on the date of issue and the remaining 50% on the one year anniversary of the date of issue so long as the recipient has not been removed as a director for cause; | ||||||||||||||||
| · | Harvey Kesner – 600,000 shares, vesting in two equal annual installments with 50% vesting immediately on the date of issue and the remaining 50% on the one year anniversary of the date of issue so long as the recipient has not been removed as a director for cause; and | ||||||||||||||||
| · | Robert Knie – 25,000, vesting immediately. | ||||||||||||||||
| Mr. Karr and Mr. Kesner were issued their respective Performance Options in addition to the Director Options described above. | |||||||||||||||||
| On January 28, 2014, the Compensation Committee of the Board of Directors adopted resolutions intended to grant 300,000 non-qualified stock options with a term of five (5) years and an exercise price of $5.83 to Anthony Hayes that would be subject to certain vesting conditions upon agreement of the Compensation Committee and Mr. Hayes. The parties failed to reach agreement prior to the date of this Quarterly Report on Form 10-Q and accordingly the stock options subject to specific performance targets were determined to be not issued, but may be issued at a future date at the discretion of the Compensation Committee. In accordance with ASC Topic 718 the failure to finalize performance targets result in the stock options not being considered to have been granted and therefore are not outstanding. | |||||||||||||||||
| On March 14, 2014, pursuant to and subject to the available number of shares reserved under the 2014 Plan, the Company issued 100,000 non-qualified options with a term of ten (10) years and an exercise price of $4.67 to Frank Reiner, an employee of the Company. The options vest in 25% increments in quarterly installments beginning July 1, 2014. | |||||||||||||||||
| On March 21, 2014, pursuant to and subject to the available number of shares reserved under the 2014 Plan, the Company issued 10,000 non-qualified options with a term of five (5) years and an exercise price of $4.29 to Hayley Behrmann, an employee of the Company. These options vest in 50% increments in six-month installments beginning September 20, 2014. | |||||||||||||||||
| The grant date fair value of stock options granted during the quarter ended March 31, 2014 was $3,840,528. The fair value of the Company’s common stock was based upon the publicly quoted price on the date that the final approval of the awards was obtained. The Company does not expect to pay dividends in the foreseeable future so therefore the dividend yield is 0%. The expected term for stock options granted with service conditions represents the average period the stock options are expected to remain outstanding and is based on the expected term calculated using the approach prescribed by the Securities and Exchange Commission's Staff Accounting Bulletin No. 110 for “plain vanilla” options. The expected term for stock options granted with performance and/or market conditions represents the estimated period estimated by management by which the performance conditions will be met. The Company obtained the risk free interest rate from publicly available data published by the Federal Reserve. The volatility rate was computed based on a comparison of average volatility rates of similar companies. No options were granted during the three months ended March 31, 2013. The fair value of options granted in 2014 was estimated using the following assumptions: | |||||||||||||||||
| For the | |||||||||||||||||
| Three Months ended | |||||||||||||||||
| March 31, | |||||||||||||||||
| 2014 | |||||||||||||||||
| Exercise price | $ | 4.29 - $5.83 | |||||||||||||||
| Expected stock price volatility | 80.5% - 90.6 | % | |||||||||||||||
| Risk-free rate of interest | 0.76% - 1.53 | % | |||||||||||||||
| Term (years) | 5.0 - 10.0 | ||||||||||||||||
| A summary of option activity under the Company’s employee stock option plan for the three months ended March 31, 2014 is presented below: | |||||||||||||||||
| Number of Shares | Weighted Average Exercise Price | Total Intrinsic Value | Weighted Average Remaining Contractual Life (in years) | ||||||||||||||
| Outstanding as of December 31, 2013 | 1,983,876 | $ | 7.14 | $ | 1,935,990 | 9.2 | |||||||||||
| Employee options granted | 1,310,000 | 5.73 | 5.2 | ||||||||||||||
| Non-employee options exercised | - | ||||||||||||||||
| Non-employee options cancelled | - | ||||||||||||||||
| Outstanding as of March 31, 2014 | 3,293,876 | $ | 6.58 | - | 7.5 | ||||||||||||
| Options vested and expected to vest | 3,293,876 | 6.58 | - | 7.5 | |||||||||||||
| Options vested and exercisable | 1,646,126 | $ | 6.59 | $ | - | 7.1 | |||||||||||
| A summary of option activity under the Company’s non-employee stock option plan for the three months ended March 31, 2014 is presented below: | |||||||||||||||||
| Number of Shares | Weighted Average Exercise Price | Total Intrinsic Value | Weighted Average Remaining Contractual Life (in years) | ||||||||||||||
| Outstanding as of December 31, 2013 | 30,000 | 7.08 | 29,400 | 9.3 | |||||||||||||
| Non-employee options granted | - | - | - | ||||||||||||||
| Non-employee options exercised | - | ||||||||||||||||
| Non-employee options cancelled | - | ||||||||||||||||
| Outstanding as of March 31, 2014 | 30,000 | 7.08 | - | 9 | |||||||||||||
| Options vested and expected to vest | 30,000 | 7.08 | - | 9 | |||||||||||||
| Options vested and exercisable | 30,000 | $ | 7.08 | $ | - | 9 | |||||||||||
| Stock-based compensation associated with the amortization of stock option expense was approximately $3.4 million and $4,000 for the three months ended March 31, 2014 and March 31, 2013, respectively. Unamortized compensation cost for these awards amounted to $7.26 million at March 31, 2014 and will be amortized over a weighted average vesting period of approximately 1.0 year. | |||||||||||||||||
| Restricted Stock Awards | |||||||||||||||||
| On March 14, 2014, pursuant to and subject to the available number of shares reserved under the 2014 Plan, the Company issued 10,000 restricted shares to Frank Reiner, an employee of the Company. The restricted stock awards vest in 25% increments in quarterly installments beginning March 14, 2014. | |||||||||||||||||
| A summary of the restricted stock award activity for the three months ended March 31, 2014 is as follows: | |||||||||||||||||
| Number of Units | Weighted Average Grant Day Fair Value | ||||||||||||||||
| Nonvested at December 31, 2013 | 250 | $ | 6.83 | ||||||||||||||
| Granted | 10,000 | 4.67 | |||||||||||||||
| Vested | (250 | ) | 4.67 | ||||||||||||||
| Forfeited | - | - | |||||||||||||||
| Nonvested at March 31, 2014 | 10,000 | $ | 4.74 | ||||||||||||||
| Stock-based Compensation | |||||||||||||||||
| Stock-based compensation for the three months ended March 31, 2014 and 2013 was comprised of the following (in thousands): | |||||||||||||||||
| For the three months ended | |||||||||||||||||
| March 31, | |||||||||||||||||
| 2014 | 2013 | ||||||||||||||||
| Employee restricted stock awards | $ | 2 | $ | 3 | |||||||||||||
| Employee stock option awards | 3,394 | 1 | |||||||||||||||
| Total compensation expense | $ | 3,396 | $ | 4 | |||||||||||||
Related_Party_Transactions
| Related Party Transactions | 3 Months Ended |
| Mar. 31, 2014 | |
| Notes to Financial Statements | ' |
| 6. Related Party Transactions | ' |
| Sichenzia Ross Friedman Ference LLP (“SRFF”), provided legal services to the Company. For the three months ended March 31, 2014, SRFF invoiced the Company on an aggregate amount of $204,708 for legal services rendered. In addition, as disclosed in Note 5, during the three months ended March 31, 2014, Mr. Kesner was awarded 75,000 non-qualified stock options (the “Director Options”) to acquire shares of the Company's common stock and 600,000 non-qualified options with a term of five (5) years and an exercise price of $5.83. Mr. Kesner is a director and partner of SRFF. | |
| On January 6, 2014, the Board of Directors of Spherix Incorporated appointed Richard Cohen as its Chief Financial Officer, and Michael Pollack resigned as the interim Chief Financial Officer of the Company, effective January 3, 2014. Mr. Cohen is serving as the Company’s Chief Financial Officer pursuant to an agreement with Chord Advisors LLC (“Chord”), of which Mr. Cohen is Chairman. In consideration for Mr. Cohen’s services, the Company has agreed to pay Chord a monthly fee of $20,000 ($5,000 of which will be payable in shares of the Company’s common stock). In April 2014, the Company modified this agreement to pay Chord a monthly fee of $20,000 in cash. | |
Commitment_and_Contingencies
| Commitment and Contingencies | 3 Months Ended | ||||
| Mar. 31, 2014 | |||||
| Notes to Financial Statements | ' | ||||
| 7. Commitment and Contingencies | ' | ||||
| Leases | |||||
| The Company’s offices are located in Tysons Corner, Virginia and Bethesda, Maryland, where it leases 837 and 5,000 square feet of office space under leases that expire on August 31, 2014 and March 31, 2018, respectively. The Company’s monthly lease payment for the Virginia office space is $1,883 per month and $13,090 per month for the Maryland office space. The Company’s subsidiary, Nuta Technology Corp., is located in the Tysons Corner, Virginia office. The capacity of the Tysons Corner and Bethesda facilities are adequate for the Company’s current needs. The Company also leases office space in New York, NY on a month-to-month basis at a monthly rate of $6,000. The Virginia lease runs from March 1, 2013 through August 31, 2014. | |||||
| Future minimum rental payments required as of March 31, 2014, remaining under the non-cancelable leases are as follows (in thousands): | |||||
| Operating Lease | |||||
| 31-Dec-14 | $ | 128 | |||
| 31-Dec-15 | 161 | ||||
| 31-Dec-16 | 165 | ||||
| 31-Dec-17 | 170 | ||||
| 31-Dec-18 | 43 | ||||
| $ | 667 | ||||
| Legal Proceedings | |||||
| In the ordinary course of business, the Company actively pursues legal remedies to enforce its intellectual property rights and to stop unauthorized use of our technology. From time to time, the Company may be involved in various claims and legal actions arising in the ordinary course of our business. There were no pending material claims or legal matters as of the date of this report other than the following matters: | |||||
| Spherix Incorporated v. Elizabethean Court Associates III Limited Partnership | |||||
| The Company has commenced a lawsuit against the landlord of the Bethesda, Maryland office claiming that the assignment of the lease to the purchaser of the Spherix Consulting business was permitted under the lease and seeking termination of the lease as a result of the landlord's failure to consent to such assignment. The lawsuit, Spherix Incorporated v. Elizabethean Court Associates III Limited Partnership ("Elizabethean"), Case No., 377142 was decided in favor of Elizabethean on March 28, 2014. On April 24, 2014 Elizabethean filed a motion for an award of attorneys' fees and costs. The Company intends to oppose the motion. The Company will continue to use the leased property in the normal course of its business and make the monthly rental payments in accordance with the terms of the lease. | |||||
| Charter Communications, Inc., Wideopenwest Finance LLC a/k/a Wow! Internet, Cable & Phone, Knology, Inc., Cequel Communications, LLC, d/b/a Suddenlink Communications, and Cable One, Inc. v Rockstar Consortium US LP, Bockstar Technologies LLC, Constellation Technologies LLC, and Spherix Incorporated. | |||||
| On January 17, 2014, an action was filed by several cable operators in the United States District Court for the District of Delaware (No 1:99-mc-09999) against Rockstar, Bockstar Technologies LLC, Constellation Technologies LLC and the Company (collectively, the “Defendants”). The complaint (the “Complaint”) was filed by Charter Communications, Inc., WideOpenWest Finance, LLC a/k/a WOW! Internet, Cable & Phone, Knology, Inc., Cequel Communications, LLC d/b/a Suddenlink Communications, and Cable One, Inc. (collectively, the “Plaintiffs”). Plaintiffs are in the communications, cable and/or wireline industries and allege that Rockstar has accused the Plaintiffs of practicing various communication and networking technologies (including many well-established technical standards), related to those industries. The complaint states that in many instances such technical standards are designed into the equipment Plaintiffs purchase from vendors, and must be implemented to interoperate with other communications providers and their end user customers. Rockstar owns (and since December 31, 2013, the Company owns) patents alleged to be infringed by Plaintiffs activities. The relief sought against the Company is principally for a declaratory judgment that Plaintiffs do not infringe the patents, requiring that the Plaintiffs be granted a patent license, that the Company has misused the patents and it and the other Defendants have waived and are estopped from enforcing the patents in the marketplace, that the Company is liable to Plaintiffs for entering into an illegal conspiracy, and assessing corresponding damages, for direct and consequential damages, attorney’s fees and costs. The Company cannot predict the outcome of this matter, however, the Company’s preliminary assessment is that the lawsuit is completely without merit and intends to vigorously defend it position. The Company has not accrued a loss for this matter. | |||||
| Registration Penalty | |||||
| As stipulated in the Registration Rider of the December 2013 Rockstar patent acquisition agreement, the Company was required to both (i) file a registration statement for the securities issued as consideration in the agreement by February 3, 2013 (unless a later date was consented to by Rockstar), and (ii) such registration statement was to be declared effective by the SEC within sixty (days) after its filing. Failure to comply with the registration requirement required that the Company issue to Rockstar additional consideration ("Additional Rockstar Shares") in the form of shares of Common Stock equal to five (5%) percent of the number of shares of Common Stock and Preferred H Stock (taken together) issued to Rockstar (subject to certain beneficial ownership restrictions). Additionally, if the issuance of "Additional Rockstar Shares" would have resulted in violation of certain beneficial ownership limitations, then the issuance of such "Additional Rockstar Shares" would be deferred until such time as the issuance would not cause Rockstar to exceed the applicable Beneficial Ownership set out with in the agreement. | |||||
| The Company filed a registration statement which was declared effective until April 16, 2014. Since the Company is required to deliver shares under a registration payment arrangement, the transfer of that consideration is probable, and the number of shares to be delivered could be reasonably estimated, the Company’s closing share price at March 31, 2014 was used to measure the contingent liability in accordance with ASC 450 “Contingencies”. The Company recorded an accrued expense of $0.7 million based on its obligation to issue 239,521 common shares at a closing price of $2.99 on March 31, 2014. | |||||
Subsequent_Events
| Subsequent Events | 3 Months Ended |
| Mar. 31, 2014 | |
| Notes to Financial Statements | ' |
| 8. Subsequent Events | ' |
| Conversions of Series D-1 Convertible Preferred Stock and Series B Convertible Preferred Stock | |
| Since March 31, 2014, shareholders have converted 382,668 shares of the Company's D-1 Convertible Preferred stock into 3,826,680 shares of common stock. Also, during this time period, a shareholder converted 1 share of the Company's B Convertible Preferred stock into 4 shares of common stock. | |
| Stock Grants | |
| On April 23, 2014, the Company issued 7,500 shares of common stock to two consultants for consulting services. | |
| On April 29, 2014, the Company issued 239,521 Additional Rockstar Shares as stipulated in the Registration Rider of the December 2013 Rockstar patent acquisition. See note 7 for further details. |
Summary_of_Significant_Account1
| Summary of Significant Accounting Policies (Policies) | 3 Months Ended | ||||||||
| Mar. 31, 2014 | |||||||||
| Summary Of Significant Accounting Policies Policies | ' | ||||||||
| Basis of Presentation and Principles of Consolidation | ' | ||||||||
| The accompanying condensed consolidated financial statements of the Company are unaudited and do not include all of the information and disclosures generally required for annual financial statements. In the opinion of management, the statements contain all material adjustments (consisting of normal recurring accruals) necessary to present fairly the Company’s consolidated financial position as of March 31, 2014, the condensed consolidated results of its operations and cash flows for the three month periods ended March 31, 2014 and 2013. This report should be read in conjunction with the Company’s Annual Report on Form 10-K, which does contain the complete information and disclosure, for the year ended December 31, 2013. | |||||||||
| The accompanying condensed consolidated financial statements include the accounts of Spherix Incorporated and its wholly-owned subsidiaries, Biospherics Incorporated, Nuta Technology Corp., Spherix Portfolio Acquisition I, Inc. ("SPXI"), Spherix Portfolio Acquisition II, Inc. ("SPXII"), Guidance IP, LLC (“Guidance”), CompuFill LLC ("CompuFill") and Directional IP, LLC. (“Directional”). All significant intercompany balances and transactions have been eliminated in consolidation. | |||||||||
| Use of Estimates | ' | ||||||||
| The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“US GAAP”). This requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the period. The Company’s significant estimates and assumptions include the recoverability and useful lives of long-lived assets, stock-based compensation, valuation of warrants, the valuation of assets acquired and common and preferred stock issued in the acquisition of North South, and the valuation allowance related to the Company’s deferred tax assets. Certain of the Company’s estimates, including the carrying amount of the intangible assets, could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates and assumptions. | |||||||||
| Intangible Assets - Patent Portfolios | ' | ||||||||
| "Intangible assets" include the Company’s patent portfolios with original estimated useful lives ranging from 6 months to 12 years. The Company amortizes the cost of the intangible assets over their estimated useful lives on a straight line basis. Costs incurred to acquire patents, including legal costs, are also capitalized as long-lived assets and amortized on a straight-line basis with the associated patent. As disclosed in Note 1, the Company acquired its current patent portfolios during 2013. | |||||||||
| "Patents" includes the cost of patents or patent rights (hereinafter, collectively “patents”), acquired from third-parties or acquired in connection with business combinations. Patent acquisition costs are amortized utilizing the straight-line method over their remaining economic useful lives, ranging from one to ten years. Certain patent application and prosecution costs incurred to secure additional patent claims, that based on management’s estimates are deemed to be recoverable, are capitalized and amortized over the remaining estimated economic useful life of the related patent portfolio. | |||||||||
| Goodwill | ' | ||||||||
| Goodwill is the excess of cost of an acquired entity over the fair value of amounts assigned to assets acquired and liabilities assumed in a business combination. Goodwill is subject to impairment testing at least annually and will be tested for impairment between annual tests if an event occurs or circumstances change that indicate the carrying amount may be impaired. ASC Topic 350 provides an entity with the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If, after assessing the totality of events or circumstances, an entity determines it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then performing the two-step impairment test is unnecessary. If the two-step impairment test is necessary, a fair-value-based test is applied at the reporting unit level, which is generally one level below the operating segment level. The test compares the fair value of an entity's reporting units to the carrying value of those reporting units. This test requires various judgments and estimates. The Company estimates the fair value of the reporting unit using a market approach in combination with a discounted operating cash flow approach. Impairment of goodwill is measured as the excess of the carrying amount of goodwill over the fair values of recognized and unrecognized assets and liabilities of the reporting unit. An adjustment to goodwill will be recorded for any goodwill that is determined to be impaired. The Company tests goodwill for impairment at least annually in conjunction with the preparation of its annual business plan, or more frequently if events or circumstances indicate it might be impaired. ASU 2010-28 modifies Step 1 of the goodwill impairment test for reporting units with zero or negative carrying amounts. For those reporting units, an entity is required to perform Step 2 of the goodwill impairment test if it is more likely than not that a goodwill impairment exists. In determining whether it is more likely than not that goodwill impairment exists, an entity should consider whether there are any adverse qualitative factors indicating that impairment may exist. | |||||||||
| Impairment of Long-lived Assets | ' | ||||||||
| The Company monitors the carrying value of long-lived assets for potential impairment and tests the recoverability of such assets whenever events or changes in circumstances indicate that the carrying amounts may not be recoverable. If a change in circumstance occurs, the Company performs a test of recoverability by comparing the carrying value of the asset or asset group to its undiscounted expected future cash flows. If cash flows cannot be separately and independently identified for a single asset, the Company will determine whether impairment has occurred for the group of assets for which the Company can identify the projected cash flows. If the carrying values are in excess of undiscounted expected future cash flows, the Company measures any impairment by comparing the fair value of the asset or asset group to its carrying value. The Company deemed there was no impairment of long-lived assets during the three months ended March 31, 2014. | |||||||||
| Net Loss Per Share | ' | ||||||||
| Basic loss per share is computed by dividing the net income or loss applicable to common shares by the weighted average number of common shares outstanding during the period. Diluted earnings per share is computed using the weighted average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares consist of the incremental common shares issuable upon the exercise of stock options (using the treasury stock method) and the conversion of the Company’s convertible preferred stock and warrants (using the if-converted method). Diluted loss per share excludes the shares issuable upon the conversion of preferred stock and the exercise of stock options and warrants from the calculation of net loss per share if their effect would be anti-dilutive. | |||||||||
| Securities that could potentially dilute loss per share in the future that were not included in the computation of diluted loss per share at March 31, 2014 and 2013 are as follows: | |||||||||
| For the three months | |||||||||
| ended March 31, | |||||||||
| 2014 | 2013 | ||||||||
| Convertible preferred stock | 16,773,275 | 229,341 | |||||||
| Warrants to purchase common stock | 775,021 | 75,757 | |||||||
| Non-vested restricted stock awards | 10,000 | 122,500 | |||||||
| Options to purchase common stock | 3,323,876 | 7,163 | |||||||
| Total | 20,882,172 | 434,761 | |||||||
| Stock-based Compensation | ' | ||||||||
| The Company accounts for share-based payment awards exchanged for employee services at the estimated grant date fair value of the award. Stock options issued under the Company’s long-term incentive plans are granted with an exercise price equal to no less than the market price of the Company’s stock at the date of grant and expire up to ten years from the date of grant. These options generally vest over a four- to ten-year period. | |||||||||
| The fair value of stock options granted was determined on the grant date using assumptions for risk free interest rate, the expected term, expected volatility, and expected dividend yield. The risk free interest rate is based on U.S. Treasury zero-coupon yield curve over the expected term of the option. The expected term assumption is determined using the weighted average midpoint between vest and expiration for all individuals within the grant. The expected volatility assumption is based on the standard deviation of the Company’s underlying stock price’s daily logarithmic returns. | |||||||||
| The Company’s model includes a zero dividend yield assumption, as the Company has not historically paid nor does it anticipate paying dividends on its common stock. The Company’s model does not include a discount for post-vesting restrictions, as the Company has not issued awards with such restrictions. | |||||||||
| The periodic expense is then determined based on the valuation of the options, and at that time an estimated forfeiture rate is used to reduce the expense recorded. The Company estimates of pre-vesting forfeitures is primarily based on the Company’s historical experience and is adjusted to reflect actual forfeitures as the options vest. | |||||||||
| Treasury Stock | ' | ||||||||
| The Company accounts for the treasury stock using the cost method, which treats it as a reduction in stockholders’ equity. | |||||||||
| Preferred Stock | ' | ||||||||
| The Company applies the accounting standards for distinguishing liabilities from equity when determining the classification and measurement of its preferred stock. Preferred shares subject to mandatory redemption are classified as liability instruments and are measured at fair value. Conditionally redeemable preferred shares (including preferred shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, preferred shares are classified as stockholders’ equity. | |||||||||
Summary_of_Significant_Account2
| Summary of Significant Accounting Policies (Tables) | 3 Months Ended | ||||||||
| Mar. 31, 2014 | |||||||||
| Summary Of Significant Accounting Policies Tables | ' | ||||||||
| Diluted earning per share Calculation | ' | ||||||||
| For the three months | |||||||||
| ended March 31, | |||||||||
| 2014 | 2013 | ||||||||
| Convertible preferred stock | 16,773,275 | 229,341 | |||||||
| Warrants to purchase common stock | 775,021 | 75,757 | |||||||
| Non-vested restricted stock awards | 10,000 | 122,500 | |||||||
| Options to purchase common stock | 3,323,876 | 7,163 | |||||||
| Total | 20,882,172 | 434,761 | |||||||
Goodwill_and_Intangible_Assets1
| Goodwill and Intangible Assets (Tables) | 3 Months Ended | ||||||||||||||||
| Mar. 31, 2014 | |||||||||||||||||
| Goodwill And Intangible Assets Tables | ' | ||||||||||||||||
| Purchase Price Allocation | ' | ||||||||||||||||
| For the three months ended | |||||||||||||||||
| 31-Mar-13 | |||||||||||||||||
| Revenues | $ | 53 | |||||||||||||||
| Net loss | $ | (3,810 | ) | ||||||||||||||
| Loss per share - basic and diluted | $ | (5.51 | ) | ||||||||||||||
| Amortization to acquired intangible assets | ' | ||||||||||||||||
| Date Acquired and Description | Intangible Assets at December 31, 2013, net | Weighted Average Life (in years) | Amortization Expense for the Three Months Ended March 31, 2014 | Amount Recorded as of March 31, 2014, net | |||||||||||||
| 7/24/13 - Rockstar patent portfolio | $ | 3,792 | 8.5 | $ | 115 | $ | 3,677 | ||||||||||
| 9/10/13 - North South patent portfolio | 1,062 | 8.5 | 32 | 1,030 | |||||||||||||
| 12/31/13 - Rockstar patent portfolio | 59,981 | 6.5 | 2,281 | 57,700 | |||||||||||||
| $ | 64,835 | $ | 2,428 | $ | 62,407 | ||||||||||||
| Future amortization of all patents | ' | ||||||||||||||||
| Rockstar | North South | Rockstar | |||||||||||||||
| Portfolio | Portfolio | Portfolio | |||||||||||||||
| Acquired | Acquired | Acquired | Total | ||||||||||||||
| July 24, | September 10, | December 13, | Amortization | ||||||||||||||
| 2013 | 2013 | 2013 | |||||||||||||||
| Nine Months Ended December 31, 2014 | 355 | 98 | 6,950 | 7,403 | |||||||||||||
| 31-Dec-15 | 470 | 130 | 9,225 | 9,825 | |||||||||||||
| 31-Dec-16 | 471 | 130 | 9,250 | 9,851 | |||||||||||||
| 31-Dec-17 | 470 | 130 | 9,225 | 9,825 | |||||||||||||
| 31-Dec-18 | 470 | 130 | 9,225 | 9,825 | |||||||||||||
| Thereafter | 1,441 | 412 | 13,825 | 15,678 | |||||||||||||
| Total | $ | 3,677 | $ | 1,030 | $ | 57,700 | $ | 62,407 | |||||||||
Stockholders_Equity_Tables
| Stockholders' Equity (Tables) | 3 Months Ended | ||||||||||||||||
| Mar. 31, 2014 | |||||||||||||||||
| Stockholders Equity Tables | ' | ||||||||||||||||
| Preferred Stock | ' | ||||||||||||||||
| Number of Shares Issued | |||||||||||||||||
| and Outstanding as of | |||||||||||||||||
| March 31, | December 31, | Par Value | Conversion Ratio | ||||||||||||||
| 2014 | 2013 | ||||||||||||||||
| Series "A" | - | - | $ | 0.0001 | N/A | ||||||||||||
| Series "B" | 1 | 1 | 0.0001 | 4:01 | |||||||||||||
| Series "C" | 1 | 1 | 0.0001 | 1:01 | |||||||||||||
| Series “D" | 18,000 | 1,227,582 | 0.0001 | 10:01 | |||||||||||||
| Series “D-1" | 945,139 | 59,265 | 0.0001 | 10:01 | |||||||||||||
| Series “E” | - | - | 0.0001 | 1:01 | |||||||||||||
| Series “F" | - | - | 0.0001 | 1:01 | |||||||||||||
| Series “F-1" | 156,250 | 156,250 | 0.0001 | 1:01 | |||||||||||||
| Series “H" | 459,043 | 459,043 | 0.0001 | 10:01 | |||||||||||||
| Series “I” | 119,760 | 119,760 | 0.0001 | 20:01 | |||||||||||||
| Summary of warrant activity | ' | ||||||||||||||||
| Warrants | Weighted Average Exercise Price | Total Intrinsic Value | |||||||||||||||
| Outstanding as of December 31, 2013 | 65,263 | $ | 5.83 | - | |||||||||||||
| Issued | 711,355 | 5.9 | |||||||||||||||
| Cancelled | (1,597 | ) | 28 | ||||||||||||||
| Outstanding as of March 31, 2014 | 775,021 | $ | 5.85 | $ | - | ||||||||||||
| Fair value of stock-based compensation | ' | ||||||||||||||||
| For the | |||||||||||||||||
| Three Months ended | |||||||||||||||||
| March 31, | |||||||||||||||||
| 2014 | |||||||||||||||||
| Exercise price | $ | 4.29 - $5.83 | |||||||||||||||
| Expected stock price volatility | 80.5% - 90.6 | % | |||||||||||||||
| Risk-free rate of interest | 0.76% - 1.53 | % | |||||||||||||||
| Term (years) | 5.0 - 10.0 | ||||||||||||||||
| Summary of option activity | ' | ||||||||||||||||
| Number of Shares | Weighted Average Exercise Price | Total Intrinsic Value | Weighted Average Remaining Contractual Life (in years) | ||||||||||||||
| Outstanding as of December 31, 2013 | 1,983,876 | $ | 7.14 | $ | 1,935,990 | 9.2 | |||||||||||
| Employee options granted | 1,310,000 | 5.73 | 5.2 | ||||||||||||||
| Non-employee options exercised | - | ||||||||||||||||
| Non-employee options cancelled | - | ||||||||||||||||
| Outstanding as of March 31, 2014 | 3,293,876 | $ | 6.58 | - | 7.5 | ||||||||||||
| Options vested and expected to vest | 3,293,876 | 6.58 | - | 7.5 | |||||||||||||
| Options vested and exercisable | 1,646,126 | $ | 6.59 | $ | - | 7.1 | |||||||||||
| Number of Shares | Weighted Average Exercise Price | Total Intrinsic Value | Weighted Average Remaining Contractual Life (in years) | ||||||||||||||
| Outstanding as of December 31, 2013 | 30,000 | 7.08 | 29,400 | 9.3 | |||||||||||||
| Non-employee options granted | - | - | - | ||||||||||||||
| Non-employee options exercised | - | ||||||||||||||||
| Non-employee options cancelled | - | ||||||||||||||||
| Outstanding as of March 31, 2014 | 30,000 | 7.08 | - | 9 | |||||||||||||
| Options vested and expected to vest | 30,000 | 7.08 | - | 9 | |||||||||||||
| Options vested and exercisable | 30,000 | $ | 7.08 | $ | - | 9 | |||||||||||
| Summary of the restricted stock award activity | ' | ||||||||||||||||
| Number of Units | Weighted Average Grant Day Fair Value | ||||||||||||||||
| Nonvested at December 31, 2013 | 250 | $ | 6.83 | ||||||||||||||
| Granted | 10,000 | 4.67 | |||||||||||||||
| Vested | (2,50 | ) | 4.67 | ||||||||||||||
| Forfeited | - | - | |||||||||||||||
| Nonvested at March 31, 2014 | 10,000 | $ | 4.74 | ||||||||||||||
| Stock-based compensation | ' | ||||||||||||||||
| For the three months ended | |||||||||||||||||
| March 31, | |||||||||||||||||
| 2014 | 2013 | ||||||||||||||||
| Employee restricted stock awards | $ | 2 | $ | 3 | |||||||||||||
| Employee stock option awards | 3,394 | 1 | |||||||||||||||
| Total compensation expense | $ | 3,396 | $ | 4 | |||||||||||||
Commitment_and_Contingencies_T
| Commitment and Contingencies (Tables) | 3 Months Ended | ||||
| Mar. 31, 2014 | |||||
| Commitment And Contingencies Tables | ' | ||||
| Future minimum rental payments | ' | ||||
| Operating Lease | |||||
| 31-Dec-14 | $ | 128 | |||
| 31-Dec-15 | 161 | ||||
| 31-Dec-16 | 165 | ||||
| 31-Dec-17 | 170 | ||||
| 31-Dec-18 | 43 | ||||
| $ | 667 | ||||
Liquidity_and_Financial_Condit1
| Liquidity and Financial Condition (Details Narrative) (USD $) | Mar. 31, 2014 | Dec. 31, 2013 | Mar. 31, 2013 | Dec. 31, 2012 |
| In Thousands, unless otherwise specified | ||||
| Liquidity And Financial Condition Details Narrative | ' | ' | ' | ' |
| Working capital | $3,500 | ' | ' | ' |
| Cash and cash equivalents | $4,503 | $3,125 | $3,447 | $4,498 |
Summary_of_Significant_Account3
| Summary of Significant Accounting Policies (Details) (USD $) | Mar. 31, 2014 | Dec. 31, 2013 |
| Summary Of Significant Accounting Policies Details | ' | ' |
| Convertible preferred stock | 16,773,275 | 229,341 |
| Warrants to purchase common stock | 775,021 | 75,757 |
| Non-vested restricted stock awards | $10,000 | $122,500 |
| Options to purchase common stock | 3,323,876 | 7,163 |
| Total | 20,882,172 | 434,761 |
Summary_of_Significant_Account4
| Summary of Significant Accounting Policies (Details Narrative) (USD $) | 3 Months Ended |
| Mar. 31, 2014 | |
| Summary Of Significant Accounting Policies Details Narrative | ' |
| Impairment of long-lived assets | $0 |
Goodwill_and_Intangible_Assets2
| Goodwill and Intangible Assets (Details) (USD $) | 3 Months Ended | |
| In Thousands, except Per Share data, unless otherwise specified | Mar. 31, 2014 | Mar. 31, 2013 |
| Revenues | $4 | $6 |
| Net loss | -7,963 | -3,697 |
| Loss per share - basic and diluted | ($1.66) | ($5.35) |
| Acquisition of North South [Member] | ' | ' |
| Revenues | ' | 53 |
| Net loss | ' | ($3,810) |
| Loss per share - basic and diluted | ' | ($5.51) |
Goodwill_and_Intangible_Assets3
| Goodwill and Intangible Assets (Details 1) (USD $) | Mar. 31, 2014 | Dec. 31, 2013 |
| In Thousands, unless otherwise specified | ||
| Intangible Assets, net | ' | $64,835 |
| Amortization Expense | 2,428 | ' |
| Amount Recorded, net | 62,407 | ' |
| 7/24/13 - Rockstar Patent Portfolio | ' | ' |
| Intangible Assets, net | ' | 3,792 |
| Weighted Average Life (in years) | '8 years 6 months | ' |
| Amortization Expense | 115 | ' |
| Amount Recorded, net | 3,677 | ' |
| 9/10/13 - North South patent portfolio | ' | ' |
| Intangible Assets, net | ' | 1,062 |
| Weighted Average Life (in years) | '8 years 6 months | ' |
| Amortization Expense | 32 | ' |
| Amount Recorded, net | 1,030 | ' |
| 12/31/13 - Rockstar Patent Portfolio | ' | ' |
| Intangible Assets, net | ' | 59,981 |
| Weighted Average Life (in years) | '6 years 6 months | ' |
| Amortization Expense | 2,281 | ' |
| Amount Recorded, net | $57,700 | ' |
Goodwill_and_Intangible_Assets4
| Goodwill and Intangible Assets (Details 2) (USD $) | Mar. 31, 2014 | Dec. 31, 2013 |
| In Thousands, unless otherwise specified | ||
| Nine Months Ended December 31, 2014 | $7,403 | ' |
| 31-Dec-15 | 9,825 | ' |
| 31-Dec-16 | 9,851 | ' |
| 31-Dec-17 | 9,825 | ' |
| 31-Dec-18 | 9,825 | ' |
| Thereafter | 15,678 | ' |
| Total | 62,407 | 64,835 |
| 7/24/13 - Rockstar Patent Portfolio | ' | ' |
| Nine Months Ended December 31, 2014 | 355 | ' |
| 31-Dec-15 | 470 | ' |
| 31-Dec-16 | 471 | ' |
| 31-Dec-17 | 470 | ' |
| 31-Dec-18 | 470 | ' |
| Thereafter | 1,441 | ' |
| Total | 3,677 | ' |
| 9/10/13 - North South patent portfolio | ' | ' |
| Nine Months Ended December 31, 2014 | 98 | ' |
| 31-Dec-15 | 130 | ' |
| 31-Dec-16 | 130 | ' |
| 31-Dec-17 | 130 | ' |
| 31-Dec-18 | 130 | ' |
| Thereafter | 412 | ' |
| Total | 1,030 | ' |
| 12/31/13 - Rockstar Patent Portfolio | ' | ' |
| Nine Months Ended December 31, 2014 | 6,950 | ' |
| 31-Dec-15 | 9,225 | ' |
| 31-Dec-16 | 9,250 | ' |
| 31-Dec-17 | 9,225 | ' |
| 31-Dec-18 | 9,225 | ' |
| Thereafter | 13,825 | ' |
| Total | $57,700 | ' |
Stockholders_Equity_Details
| Stockholders' Equity (Details) (USD $) | Mar. 31, 2014 | Dec. 31, 2013 |
| Par Value | $0.00 | $0.00 |
| Series A Preferred Stock [Member] | ' | ' |
| Number of Shares Issued and Outstanding | ' | ' |
| Par Value | $0.00 | ' |
| Conversion Ratio | '4:01 | ' |
| Series B Preferred Stock [Member] | ' | ' |
| Number of Shares Issued and Outstanding | 1 | ' |
| Par Value | $0.00 | ' |
| Conversion Ratio | '1:01 | ' |
| Series C Convertible Preferred Stock [Member] | ' | ' |
| Number of Shares Issued and Outstanding | 1 | 1 |
| Par Value | $0.00 | ' |
| Conversion Ratio | '10:01 | ' |
| Series D Preferred Stock [Member] | ' | ' |
| Number of Shares Issued and Outstanding | 18,000 | 1 |
| Par Value | $0.00 | ' |
| Conversion Ratio | '10:01 | ' |
| Series D-1 Preferred [Member] | ' | ' |
| Number of Shares Issued and Outstanding | 945,139 | 156,250 |
| Par Value | $0.00 | ' |
| Conversion Ratio | '1:01 | ' |
| Series E Convertible Preferred Stock [Member] | ' | ' |
| Number of Shares Issued and Outstanding | ' | 1,227,582 |
| Par Value | $0.00 | ' |
| Conversion Ratio | '1:01 | ' |
| Series F Convertible Preferred Stock [Member] | ' | ' |
| Number of Shares Issued and Outstanding | ' | 59,265 |
| Par Value | $0.00 | ' |
| Conversion Ratio | '1:01 | ' |
| Series F-1 Convertible Preferred Stock [Member] | ' | ' |
| Number of Shares Issued and Outstanding | 156,250 | ' |
| Par Value | $0.00 | ' |
| Conversion Ratio | '10:01 | ' |
| Series H Convertible Preferred Stock [Member] | ' | ' |
| Number of Shares Issued and Outstanding | 459,043 | ' |
| Par Value | $0.00 | ' |
| Conversion Ratio | '20:01 | ' |
| Series I Preferred Stock [Member] | ' | ' |
| Number of Shares Issued and Outstanding | 119,760 | ' |
| Par Value | $0.00 | ' |
| Conversion Ratio | '20:01 | ' |
| Series H Convertible Preferred Stock | ' | ' |
| Number of Shares Issued and Outstanding | ' | 459,043 |
| Series I Convertible Preferred Stock | ' | ' |
| Number of Shares Issued and Outstanding | ' | 119,760 |
Stockholders_Equity_Details_1
| Stockholders' Equity (Details 1) (USD $) | 3 Months Ended | |
| Mar. 31, 2014 | Dec. 31, 2013 | |
| Number of Shares | ' | ' |
| Outstanding at beginning of year | ' | 7,163 |
| Outstanding at end of year | 3,323,876 | 7,163 |
| Warrants | ' | ' |
| Number of Shares | ' | ' |
| Outstanding at beginning of year | 65,263 | ' |
| Issued | 711,355 | ' |
| Cancelled | -1,597 | ' |
| Outstanding at end of year | 775,021 | ' |
| Weighted Average Exercise Price | ' | ' |
| Outstanding at beginning of year | $5.83 | ' |
| Issued | $5.90 | ' |
| Cancelled | $28 | ' |
| Outstanding at end of year | $5.85 | ' |
| Aggregate Intrinsic Value | ' | ' |
| Total Intrinsic Value | ' | ' |
Stockholders_Equity_Details_2
| Stockholders' Equity (Details 2) (Warrants, USD $) | 3 Months Ended |
| Mar. 31, 2014 | |
| Minimum [Member] | ' |
| Exercise price | $4.29 |
| Expected stock price volatility | 80.50% |
| Risk-free interest rate | 0.76% |
| Expected Term (years) | '5 years |
| Maximum [Member] | ' |
| Exercise price | $5.83 |
| Expected stock price volatility | 90.60% |
| Risk-free interest rate | 1.53% |
| Expected Term (years) | '10 years |
Stockholders_Equity_Details_3
| Stockholders' Equity (Details 3) (USD $) | 3 Months Ended | 12 Months Ended |
| In Thousands, except Share data, unless otherwise specified | Mar. 31, 2014 | Dec. 31, 2013 |
| Number of Shares | ' | ' |
| Outstanding at end of year | 3,323,876 | 7,163 |
| Employee | ' | ' |
| Number of Shares | ' | ' |
| Outstanding at beginning of year | 1,983,876 | ' |
| Employee Options granted | 1,310,000 | ' |
| Non-employee options exercised | ' | ' |
| Non-employee options cancelled | ' | ' |
| Outstanding at end of year | 3,293,876 | 1,983,876 |
| Options vested and expected to vest | 3,293,876 | ' |
| Options vested and exercisable | 1,646,126 | ' |
| Weighted Average Exercise Price | ' | ' |
| Outstanding at beginning of year | $7.14 | ' |
| Employee Options granted | $5.73 | ' |
| Outstanding at end of year | $6.58 | $7.14 |
| Options vested and expected to vest | $6.51 | ' |
| Options vested and exercisable | $6.59 | ' |
| Aggregate Intrinsic Value | ' | ' |
| Aggregate intrinsic value of share outstanding, beginning | $1,935,990 | ' |
| Aggregate intrinsic value of share outstanding, beginning | ' | 1,935,990 |
| Options vested and expected to vest | ' | ' |
| Options vested and exercisable | ' | ' |
| Weighted Average Remaining Contractual Life | ' | ' |
| Weighted average remaining contractual life of share outstanding | '7 years 3 months 18 days | '9 years 2 months 12 days |
| Weighted average remaining contractual life of share Options granted | ' | '5 years 2 months 6 days |
| Options vested and expected to vest | '7 years 6 months | ' |
| Options vested and exercisable | '7 years 2 months 1 day | ' |
Stockholders_Equity_Details_4
| Stockholders' Equity (Details 4) (USD $) | 3 Months Ended | 12 Months Ended |
| In Thousands, except Share data, unless otherwise specified | Mar. 31, 2014 | Dec. 31, 2013 |
| Number of Shares | ' | ' |
| Outstanding at end of year | 3,323,876 | 7,163 |
| Non Employee | ' | ' |
| Number of Shares | ' | ' |
| Outstanding at beginning of year | 30,000 | ' |
| Non Employee Options granted | ' | ' |
| Non Employee Options exercised | ' | ' |
| Non Employee Options cancelled | ' | ' |
| Outstanding at end of year | 30,000 | 30,000 |
| Options vested and expected to vest | 30,000 | ' |
| Options vested and exercisable | 30,000 | ' |
| Weighted Average Exercise Price | ' | ' |
| Outstanding at beginning of year | $7.08 | ' |
| Non Employee Options granted | ' | ' |
| Outstanding at end of year | $7.08 | $7.08 |
| Options vested and expected to vest | $7.08 | ' |
| Options vested and exercisable | $7.08 | ' |
| Aggregate Intrinsic Value | ' | ' |
| Aggregate intrinsic value of share outstanding | ' | $29,400 |
| Options vested and expected to vest | ' | ' |
| Options vested and exercisable | ' | ' |
| Weighted Average Remaining Contractual Life | ' | ' |
| Weighted average remaining contractual life of share outstanding | ' | '9 years 3 months 15 days |
| Weighted average remaining contractual life of share Options granted | '9 years | ' |
| Options vested and expected to vest | '9 years | ' |
| Options vested and exercisable | '9 years | ' |
Stockholders_Equity_Details_5
| Stockholders' Equity (Details 5) (USD $) | 3 Months Ended |
| Mar. 31, 2014 | |
| Notes to Financial Statements | ' |
| Nonvested shares outstanding, Beginning | 250 |
| Nonvested shares granted | 10,000 |
| Nonvested shares vested | -250 |
| Nonvested shares forfeited | ' |
| Nonvested shares outstanding, Ending | 10,000 |
| Nonvested shares outstanding, weighted average grant date fair value, Beginning | $6.83 |
| Nonvested shares granted, weighted average grant date fair value | $4.67 |
| Nonvested shares vested, weighted average grant date fair value | $4.67 |
| Nonvested shares forfeited, weighted average grant date fair value | ' |
| Nonvested shares outstanding, weighted average grant date fair value, Beginning | $4.74 |
Stockholders_Equity_Details_6
| Stockholders' Equity (Details 6) (USD $) | 3 Months Ended | |
| In Thousands, unless otherwise specified | Mar. 31, 2014 | Mar. 31, 2013 |
| Stock option awards | $75 | ' |
| Total compensation expense | 3,396 | 4 |
| Employee | ' | ' |
| Restricted stock awards | 2 | 3 |
| Stock option awards | $3,394 | $1 |
Stockholders_Equity_Details_Na
| Stockholders' Equity (Details Narrative) (USD $) | 3 Months Ended | ||
| In Thousands, except Share data, unless otherwise specified | Mar. 31, 2014 | Mar. 31, 2013 | Dec. 31, 2013 |
| Unamortized compensation cost | $7,260,000 | ' | ' |
| Stock-based compensation | 3,396 | 4 | ' |
| Preferred stock, shares designated | 5,000,000 | ' | 5,000,000 |
| Fair value of stock options granted | $3,840 | ' | ' |
| Series A Preferred Stock [Member] | ' | ' | ' |
| Preferred stock, shares designated | 500,000 | ' | ' |
| Preferred stock, shares outstanding | 0 | ' | 0 |
| Preferred stock, shares issued | 0 | ' | 0 |
| Series I Preferred Stock [Member] | ' | ' | ' |
| Preferred stock, shares outstanding | 119,760 | ' | ' |
| Series I Convertible Preferred Stock | ' | ' | ' |
| Preferred stock, shares outstanding | ' | ' | 119,760 |
| Preferred stock, shares issued | ' | ' | 119,760 |
| Series H Convertible Preferred Stock [Member] | ' | ' | ' |
| Preferred stock, shares outstanding | 459,043 | ' | 459,043 |
| Preferred stock, shares issued | 459,043 | ' | 459,043 |
| Series B Preferred Stock [Member] | ' | ' | ' |
| Preferred stock, shares outstanding | 1 | ' | 1 |
| Preferred stock, shares issued | 1 | ' | 1 |
| Series C Convertible Preferred Stock [Member] | ' | ' | ' |
| Preferred stock, shares outstanding | 1 | ' | 1 |
| Preferred stock, shares issued | 1 | ' | 1 |
| Series D Preferred Stock [Member] | ' | ' | ' |
| Preferred stock, shares outstanding | 18,000 | ' | 1,227,582 |
| Preferred stock, shares issued | 18,000 | ' | 1,227,582 |
| Series F-1 Convertible Preferred Stock [Member] | ' | ' | ' |
| Preferred stock, shares outstanding | 156,250 | ' | 156,250 |
| Preferred stock, shares issued | 156,250 | ' | 156,250 |
| Series D-1 Preferred [Member] | ' | ' | ' |
| Preferred stock, shares outstanding | 945,139 | ' | 59,265 |
| Preferred stock, shares issued | 945,139 | ' | 59,265 |
Related_Party_Transactions_Det
| Related Party Transactions (Details Narrative) (USD $) | 3 Months Ended |
| Mar. 31, 2014 | |
| Notes to Financial Statements | ' |
| Legal services fees | $204,708 |
| Awarded non-qualified stock options to related party | 75,000 |
Commitment_and_Contingencies_D
| Commitment and Contingencies (Details) (USD $) | Mar. 31, 2014 |
| In Thousands, unless otherwise specified | |
| Notes to Financial Statements | ' |
| 2014 | $128 |
| 2015 | 161 |
| 2016 | 165 |
| 2017 | 170 |
| 2018 | 43 |
| Total | $667 |
Commitment_and_Contingencies_D1
| Commitment and Contingencies (Details Narrative) (USD $) | 3 Months Ended |
| Mar. 31, 2014 | |
| Accrued expense | $700,000 |
| Common stock obligation | 239,521 |
| Common stock obligation, share price | $2.99 |
| Virginia office [Member] | ' |
| Lease rental expenses | 1,883 |
| Maryland office [Member] | ' |
| Lease rental expenses | $13,090 |
Subsequent_Events_Details_Narr
| Subsequent Events (Details Narrative) | 1 Months Ended |
| 8-May-14 | |
| Series D-1 Preferred [Member] | ' |
| Preferred shares converted to common stock | 382,668 |
| Shares of common issued upon conversion of preferred stock | 3,826,680 |
| Series B Preferred Stock [Member] | ' |
| Preferred shares converted to common stock | 1 |
| Shares of common issued upon conversion of preferred stock | 4 |
| Consultant [Member] | ' |
| Common stock issued for services | 7,500 |
| Rockstar [Member] | ' |
| Patent acquisition shares issued | 239,521 |